Skip to main content
. 2017 Jun 22;117(3):409–420. doi: 10.1038/bjc.2017.191

Figure 1.

Figure 1

Expression of miR-145-5p/3p in clinical prostate specimens, associations with prognosis, and functional analysis. (A) Expression levels of miR-145-5p in PCa clinical specimens and cell lines. RNU48 was used for normalisation. (B) Expression levels of miR-145-3p in PCa clinical specimens and cell lines. RNU48 was used for normalisation. (C) Correlations among the relative expression levels of miR-145-5p and miR-145-3p. (D) Kaplan-Meier analysis of miR-145-3p expression and progression-free survival (GSE 21036). (E) Kaplan-Meier analysis of miR-145-5p expression and progression-free survival (GSE 21036). (F–H) Cell proliferation, migration and invasion assays. *P<0.0001. The bars indicate SDs.